Check out our most popular compounded medications! Get Started
Compounding Services

Sterile Compounding

At Bayview Pharmacy we compound sterile preparations in our USP 797 sterile laboratory. Each is made only on a prescriber's order.
two capsules

Sterile preparations, including injections, ophthalmic solutions, and intravenous infusions, are compounded in our USP 797 sterile laboratory under our documented quality program.

Our Customized Treatment Options

The sections below cover the sterile preparations prescribers most often ask us to compound: injectables for erectile dysfunction, ophthalmic solutions, and intravenous infusions for hospice care. Each is made only on a prescriber's order.

Injections

At Bayview Pharmacy we compound injectable preparations for erectile dysfunction in our USP 797 sterile laboratory, under our documented quality program.

Injectable therapy is one route prescribers use for erectile dysfunction. Each formulation is compounded to the concentration your prescriber specifies; discuss risks and side effects with them.

Single-Agent Therapy Injections

Alprostadil

Alprostadil is a single-agent injectable for erectile dysfunction. It acts locally to relax vascular smooth muscle in the penis, increasing blood flow during sexual arousal.

Alprostadil 20 mcg/ml Injection Solution
Alprostadil 20 mcg/ml Injection Solution
Alprostadil 20 mcg/mL, single-agent intracavernosal injection. Prescribed and dose-titrated by a practitioner.
Alprostadil 40 mcg/ml Injection Solution
Alprostadil 40 mcg/ml Injection Solution
Alprostadil 40 mcg/mL, single-agent intracavernosal injection. Prescribed and dose-titrated by a practitioner.

Alprostadil is one option a prescriber may select. It is administered by intracavernosal injection and dose-titrated by the practitioner.

Bi-Mix Injections

Papaverine/Phentolamine

Bi-Mix combines two active ingredients, papaverine and phentolamine. Papaverine relaxes smooth muscle and phentolamine causes vasodilation.

Bi-Mix 30-1 mg/ml Injection Solution
Bi-Mix 30-1 mg/ml Injection Solution
Papaverine 30 mg/mL and phentolamine 1 mg/mL. Prescribed and dose-titrated by a practitioner.
Bi-Mix 30-2 mg/ml Injection Solution
Bi-Mix 30-2 mg/ml Injection Solution
Papaverine 30 mg/mL and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.

Bi-Mix is one of several injectable formulations a prescriber may select. Prescribers consider prior therapy and response when choosing a formulation.

Tri-Mix without Atropine Injections

Alprostadil/Papaverine/Phentolamine

Tri-Mix without Atropine includes three active ingredients: alprostadil, papaverine, and phentolamine. Your prescriber determines which formulation is appropriate.

Tri-mix 5 mcg/ 30-1 mg/ml Injection Solution
Tri-mix 5 mcg/ 30-1 mg/ml Injection Solution
Alprostadil 5 mcg/mL, papaverine 30 mg/mL, and phentolamine 1 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 10 mcg/ 30-1 mg/ml Injection Solution
Tri-mix 10 mcg/ 30-1 mg/ml Injection Solution
Alprostadil 10 mcg/mL, papaverine 30 mg/mL, and phentolamine 1 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 20 mcg/ 30-1 mg/ml Injection Solution
Tri-mix 20 mcg/ 30-1 mg/ml Injection Solution
Alprostadil 20 mcg/mL, papaverine 30 mg/mL, and phentolamine 1 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 20 mcg/ 30-2 mg/ml Injection Solution
Tri-mix 20 mcg/ 30-2 mg/ml Injection Solution
Alprostadil 20 mcg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 30 mcg/ 30-1 mg/ml Injection Solution
Tri-mix 30 mcg/ 30-1 mg/ml Injection Solution
Alprostadil 30 mcg/mL, papaverine 30 mg/mL, and phentolamine 1 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 30 mcg/ 30-2 mg/ml Injection Solution
Tri-mix 30 mcg/ 30-2 mg/ml Injection Solution
Alprostadil 30 mcg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 40 mcg/ 30-1 mg/ml Injection Solution
Tri-mix 40 mcg/ 30-1 mg/ml Injection Solution
Alprostadil 40 mcg/mL, papaverine 30 mg/mL, and phentolamine 1 mg/mL. Prescribed and dose-titrated by a practitioner.
Tri-mix 40 mcg/ 30-2 mg/ml Injection Solution
Tri-mix 40 mcg/ 30-2 mg/ml Injection Solution
Alprostadil 40 mcg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.

Tri-Mix without Atropine is one of the injectable formulations a prescriber may select when they prefer to avoid atropine. It is prescribed and dose-titrated by a practitioner.

Tri-Mix with Atropine Injections

Atropine/Papaverine/Phentolamine

Tri-Mix with Atropine combines three active ingredients: atropine, papaverine, and phentolamine. Atropine is an anticholinergic agent included to support smooth muscle relaxation. Your prescriber determines which formulation is appropriate.

Atropine Trimix 0.15-30-2 mg/ml Injection Solution
Atropine Trimix 0.15-30-2 mg/ml Injection Solution
Atropine 0.15 mg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.

Tri-Mix with Atropine is one of several injectable formulations a prescriber may select. It is prescribed and dose-titrated by a practitioner.

Quad-Mix Injections

Alprostadil/Atropine/Papaverine/Phentolamine

Quad-Mix combines four active ingredients: alprostadil, atropine, papaverine, and phentolamine. It is prescribed at a practitioner's discretion.

Quad-mix 20 mcg/ 0.15-30-2 mg/ml Injection Solution
Quad-mix 20 mcg/ 0.15-30-2 mg/ml Injection Solution
Alprostadil 20 mcg/mL with atropine 0.15 mg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.
Quad-mix 30 mcg/ 0.15-30-2 mg/ml Injection Solution
Quad-mix 30 mcg/ 0.15-30-2 mg/ml Injection Solution
Alprostadil 30 mcg/mL with atropine 0.15 mg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.
Quad-mix 40 mcg/ 0.15-30-2 mg/ml Injection Solution
Quad-mix 40 mcg/ 0.15-30-2 mg/ml Injection Solution
Alprostadil 40 mcg/mL with atropine 0.15 mg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL. Prescribed and dose-titrated by a practitioner.

Quad-Mix is prescribed and dose-titrated by a practitioner. Your prescriber determines whether it is appropriate.

Our Tailored Ophthalmic Care Solutions

Eye conditions differ from patient to patient, and prescribers sometimes need a strength, vehicle, or combination that is not commercially manufactured. We compound ophthalmic preparations to those specifications.

Myopia Control

Myopia, or nearsightedness, is a common vision issue that often develops in childhood and progresses over time. Controlling its progression is essential to prevent more severe visual impairment in the future.

We compound atropine ophthalmic drops in low concentrations, including 0.01%, that prescribers use in myopia management protocols. The concentration is selected by the prescribing optometrist or ophthalmologist for each child.

Popular Formulations for Managing Myopia

We compound atropine ophthalmic drops in the range of low concentrations used in myopia management protocols, so the prescriber can select the concentration for each patient.

Atropine 0.01% Ophthalmic Drops
Atropine 0.01% Ophthalmic Drops
Atropine 0.01% ophthalmic drops, compounded at the concentration the prescribing optometrist or ophthalmologist specifies for myopia management.
Atropine 0.02% Ophthalmic Drops
Atropine 0.02% Ophthalmic Drops
Atropine 0.02% ophthalmic drops, one of the low concentrations prescribers use in myopia management protocols.
Atropine 0.05% Ophthalmic Drops
Atropine 0.05% Ophthalmic Drops
Atropine 0.05% ophthalmic drops, one of the low concentrations prescribers use in myopia management protocols.

Myopia management is directed by your child's optometrist or ophthalmologist. We compound the atropine concentration they prescribe.

Inflammatory Eye Conditions

Inflammatory eye conditions can cause discomfort, redness, and swelling, and may lead to long-term damage if they are not managed. Prescribers select agents that act on the inflammatory process at the ocular surface.

Our ophthalmic solutions for inflammatory eye conditions include Tacrolimus, Hydrocortisone, and Methylprednisolone formulations, compounded to the concentration and vehicle your prescriber specifies.

Popular Formulations for Inflammatory Eye Conditions

Preparations for inflammatory eye conditions are compounded with the corticosteroid or immunomodulator your prescriber specifies.

Tacrolimus 0.03% Oil Ophthalmic Solution
Tacrolimus 0.03% Oil Ophthalmic Solution
Tacrolimus 0.03% in an oil vehicle, a topical immunomodulator compounded for inflammatory eye conditions as prescribed.
Hydrocortisone 25 mg/mL Ophthalmic Solution
Hydrocortisone 25 mg/mL Ophthalmic Solution
Hydrocortisone 25 mg/mL ophthalmic solution, a corticosteroid compounded for inflammatory eye conditions as prescribed.
Methylprednisolone Sodium Succinate 1% Ophthalmic Solution
Methylprednisolone Sodium Succinate 1% Ophthalmic Solution
Methylprednisolone sodium succinate 1% ophthalmic solution, a corticosteroid compounded to prescriber specification.

Inflammatory eye conditions are managed by your eye care provider. We compound the anti-inflammatory preparation they prescribe.

Bacterial Eye Infections

Bacterial eye infections can lead to serious complications if they are not treated promptly. Prescribers managing them often specify antibiotics at concentrations that are not commercially manufactured.

We compound fortified and broad-spectrum ophthalmic solutions including vancomycin, amikacin, cefazolin, penicillin G, oxacillin, and ceftriaxone, at the concentrations your prescriber orders.

Compounded Antibiotic Preparations for Bacterial Eye Infections

Antibiotic ophthalmic preparations are compounded to the strength and vehicle the prescriber specifies for bacterial eye infections.

Vancomycin 25 mg/ml Ophthalmic Solution (Fortified)
Vancomycin 25 mg/ml Ophthalmic Solution (Fortified)
Fortified vancomycin 25 mg/mL ophthalmic solution, compounded at the concentration your prescriber orders for bacterial eye infections.
Amikacin 25 mg/mL Ophthalmic Solution
Amikacin 25 mg/mL Ophthalmic Solution
Amikacin 25 mg/mL ophthalmic solution, an aminoglycoside antibiotic compounded to prescriber specification.
Cefazolin 50 mg/mL Ophthalmic Solution
Cefazolin 50 mg/mL Ophthalmic Solution
Cefazolin 50 mg/mL ophthalmic solution, a cephalosporin antibiotic compounded to prescriber specification.
Penicillin G Potassium 333,000mU/ml Ophthalmic Solution
Penicillin G Potassium 333,000mU/ml Ophthalmic Solution
Penicillin G potassium 333,000 units/mL ophthalmic solution, compounded at the concentration your prescriber orders.
Oxacillin 66 mg/mL Ophthalmic Solution
Oxacillin 66 mg/mL Ophthalmic Solution
Oxacillin 66 mg/mL ophthalmic solution, a penicillinase-resistant penicillin compounded to prescriber specification.
Ceftriaxone 50 mg/mL Ophthalmic Solution
Ceftriaxone 50 mg/mL Ophthalmic Solution
Ceftriaxone 50 mg/mL ophthalmic solution, a cephalosporin antibiotic compounded to prescriber specification.

Fortified antibiotic ophthalmic solutions are compounded to the concentration your prescriber orders.

Customized Hospice Treatment Options

Our infusion therapies are compounded for the pain and symptom management protocols hospice teams prescribe. Concentrations are set by the prescriber.

Sterile Intravenous Infusions for Hospice Care

We compound intravenous infusions to the concentrations the hospice prescriber orders, and work directly with the hospice team on each order. Morphine, hydromorphone, ketamine, and midazolam are controlled substances and require a valid prescription.

Intravenous Infusions for Hospice Care

Our intravenous infusions are compounded for pain, sedation, and symptom management as the hospice team directs.

Morphine Sulfate 5 mg/mL Intravenous Infusion
Morphine Sulfate 5 mg/mL Intravenous Infusion
Morphine sulfate 5 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Morphine Sulfate 20 mg/mL Intravenous Infusion
Morphine Sulfate 20 mg/mL Intravenous Infusion
Morphine sulfate 20 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Morphine Sulfate 40 mg/mL Intravenous Infusion
Morphine Sulfate 40 mg/mL Intravenous Infusion
Morphine sulfate 40 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Hydromorphone 1 mg/mL Intravenous Infusion
Hydromorphone 1 mg/mL Intravenous Infusion
Hydromorphone 1 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Hydromorphone 5 mg/mL Intravenous Infusion
Hydromorphone 5 mg/mL Intravenous Infusion
Hydromorphone 5 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Hydromorphone 10 mg/mL Intravenous Infusion
Hydromorphone 10 mg/mL Intravenous Infusion
Hydromorphone 10 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Hydromorphone 20 mg/mL Intravenous Infusion
Hydromorphone 20 mg/mL Intravenous Infusion
Hydromorphone 20 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Hydromorphone 40 mg/mL Intravenous Infusion
Hydromorphone 40 mg/mL Intravenous Infusion
Hydromorphone 40 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule II controlled substance; prescription required.
Ketamine 10 mg/mL Intravenous Infusion
Ketamine 10 mg/mL Intravenous Infusion
Ketamine 10 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule III controlled substance; prescription required.
Ketamine 50 mg/mL Intravenous Infusion
Ketamine 50 mg/mL Intravenous Infusion
Ketamine 50 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule III controlled substance; prescription required.
Dexmedetomidine HCl 40 mcg/mL Intravenous Infusion
Dexmedetomidine HCl 40 mcg/mL Intravenous Infusion
Dexmedetomidine HCl 40 mcg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Prescription required.
Haloperidol Lactate 1 mg/mL Intravenous Infusion
Haloperidol Lactate 1 mg/mL Intravenous Infusion
Haloperidol lactate 1 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Prescription required.
Midazolam 5 mg/mL Intravenous Infusion
Midazolam 5 mg/mL Intravenous Infusion
Midazolam 5 mg/mL intravenous infusion, compounded at the concentration the hospice prescriber orders. Schedule IV controlled substance; prescription required.

We compound intravenous infusions to the concentrations the hospice prescriber orders, and work directly with the hospice team on each order.